Increased activity of procoagulant factors in patients with small cell lung cancer.
Small cell lung cancer (SCLC) patients have augmented risk of developing venous thromboembolism, but the mechanisms triggering this burden on the coagulation system remain to be understood. Recently, cell-derived microparticles carrying procoagulant phospholipids (PPL) and tissue factor (TF) in thei...
Enregistré dans:
| Auteurs principaux: | Shona Pedersen, Anne Flou Kristensen, Ursula Falkmer, Gunna Christiansen, Søren Risom Kristensen |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Public Library of Science (PLoS)
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/e5944bdfb83b4c8b9bb3e2e9e0d318e8 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Shotgun-based proteomics of extracellular vesicles in Alzheimer’s disease reveals biomarkers involved in immunological and coagulation pathways
par: Jonas Ellegaard Nielsen, et autres
Publié: (2021) -
Engineered factor Xa variants retain procoagulant activity independent of direct factor Xa inhibitors
par: Daniël Verhoef, et autres
Publié: (2017) -
Golden berry 4β-hydroxywithanolide E prevents tumor necrosis factor α-induced procoagulant activity with enhanced cytotoxicity against human lung cancer cells
par: Kan-Yen Hsieh, et autres
Publié: (2021) -
Circulating Tissue Factor-Positive Procoagulant Microparticles in Patients with Type 1 Diabetes
par: Zhang C, et autres
Publié: (2020) -
Liposomes bearing fibrinogen could potentially interfere with platelet interaction and procoagulant activity
par: Hernández MR, et autres
Publié: (2012)